1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics 2022 - Europe

Pathology Analysis & Statistics 2022 - Europe

1-30 of about 200 reports

EU5 Trauma Fixation Market Outlook to 2025 - External Fixators and Internal Fixators

  • $ 5995
  • February 2021
  • 135 pages

EU5 Trauma Fixation Market Outlook to 2025 - External Fixators and Internal Fixators Summary “EU5 Trauma Fixation Market Outlook to 2025” is a comprehensive databook report, covering key market ...

  • Europe
  • United Kingdom
  • Orthopedics
  • Infectious Disease
  • Investor presentation
  • Company
  • Medical Technology Density
  • Direct Sales

Company Analysis: Shionogi

  • $ 3000
  • January 2021
  • 40 pages

PharmaVitae explores Shionogi’s prescription pharmaceutical performance and outlook through to 2029. Snapshot Overview – PharmaVitae forecasts Shionogi’s revenue to remain flat through 2029, ...

  • Japan
  • United States
  • Prescription Drug
  • Influenza
  • Company research
  • Company

Company Analysis: Astellas

  • $ 3000
  • January 2021
  • 45 pages

PharmaVitae explores Astellas’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Astellas is forecast to grow revenue until 2026, at which point flagship ...

  • United States
  • Europe
  • Prostate Cancer
  • Company research
  • Company

Company Analysis: Gilead

  • $ 3000
  • January 2021
  • 67 pages

PharmaVitae explores Gilead’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Gilead’s sales will remain broadly stable over the medium term due to its ...

  • United States
  • Europe
  • Prescription Drug
  • Autoimmune Disease
  • Company research
  • Company

Company Analysis: UCB

  • $ 3000
  • January 2021
  • 38 pages

PharmaVitae explores UCB’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – UCB will experience impressive growth of its core portfolio of CNS and IandI ...

  • Europe
  • Prescription Drug
  • Clinical Trial
  • Company research
  • Company

Cystic Fibrosis - Pipeline Review, H2 2020

  • $ 2500
  • October 2020
  • 550 pages

Cystic Fibrosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Pipeline Review, H2 2020, provides an overview of the Cystic Fibrosis ...

  • Europe
  • World
  • Cystic Fibrosis
  • Company research
  • Company

Johnson & Johnson Company Analysis, Pharma Intelligence

  • $ 3000
  • July 2020
  • 62 pages

PharmaVitae explores Johnson and Johnson’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Johnson and Johnson’s growth will be driven by its pharmaceuticals ...

  • United States
  • Europe
  • Pharmaceutical
  • Leukemia
  • Company research
  • Company

UCB Company Analysis

  • $ 3000
  • July 2020
  • 43 pages

PharmaVitae explores UCB’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – UCB will experience impressive growth of its core portfolio of CNS and IandI products ...

  • Europe
  • Prescription Drug
  • Clinical Trial
  • Company research
  • Company

Cystic Fibrosis - Pipeline Review, H1 2020

  • $ 2000
  • April 2020
  • 502 pages

Cystic Fibrosis - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Pipeline Review, H1 2020, provides an overview of the Cystic Fibrosis ...

  • Europe
  • World
  • Cystic Fibrosis
  • Company research
  • Company

United Kingdom Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others.

  • $ 5995
  • January 2020
  • 249 pages

United Kingdom Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. Summary new report, United Kingdom Neurology ...

  • United Kingdom
  • Neurology
  • Neurological Disorder
  • Annual report
  • Company
  • Direct Sales
  • Prescription Drug Sales

Retrovirus Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • December 2019
  • 123 pages

Retrovirus Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Retrovirus Rapid Tests & Point of Care (POC) - Medical Devices Pipeline ...

  • World
  • Europe
  • HIV AIDS
  • Clinical Trial
  • Annual report
  • Company
  • Biologics Approval
  • Direct Sales

Insurance in Belgium - Coronavirus (COVID-19) Sector Impact

  • $ 1995
  • April 2020
  • 24 pages

Insurance in Belgium - Coronavirus (COVID-19) Sector Impact Summary ’Insurance in Belgium - Coronavirus (COVID-19) Sector Impact’ report provides brief review of the key trends and evolving developments ...

  • Belgium
  • Infectious Disease
  • Investor presentation
  • Company
  • Gross Written Premium
  • Gross Domestic Product

genedrive plc (GDR) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 60 pages

Summary Genedrive Plc (Genedrive), formerly Epistem Holdings plc, develops and markets point of need molecular diagnostics platform for identifying infectious diseases and pathogens and providing othe ...

  • Netherlands
  • Infectious Disease
  • Influenza
  • Investor presentation
  • Company
  • Medical Devices Sales
  • Manufacturing Orders

Proteome Sciences Plc (PRM) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 45 pages

Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services.Its proteomics services include drug ...

  • Europe
  • World
  • Dementia
  • Investor presentation
  • Company
  • Direct Sales
  • Medical Devices Sales

Genetic Signatures Ltd (GSS) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 31 pages

Summary Genetic Signatures Ltd (Genetic Signatures) formerly Human Genetic Signatures Pty Ltd, is a molecular diagnostics company.The company designs and manufactures real-time polymerase chain reaction ...

  • Europe
  • Netherlands
  • Infectious Disease
  • Clinical Trial
  • Investor presentation
  • Company
  • Medical Devices Sales

Biocartis Group NV (BCART) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 73 pages

Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics.The company undertakes the development ...

  • China
  • Belgium
  • Healthcare
  • Diagnostics
  • Investor presentation
  • Company
  • Direct Sales
  • Paid Claims

Grifols SA (GRF) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 75 pages

Summary Grifols SA (Grifols) is a pharmaceutical and chemical manufacturer that focuses on enhancing the health and well-being of people around the world.It conducts research, development, manufacturing ...

  • World
  • United States
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Company research
  • Company
  • Biologics Sales
  • Drug Approval

Novacyt SA (ALNOV) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • December 2021
  • 54 pages

Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions.The company offers oncology and infectious disease diagnostic products. It also sells diagnostic ...

  • World
  • Europe
  • Infectious Disease
  • Annual report
  • Company
  • Direct Sales
  • Medical Devices Sales

Quidel Corp (QDEL) - Product Pipeline Analysis, 2021 Update

  • $ 750
  • June 2021
  • 120 pages

Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions.Its major products include ...

  • Bulgaria
  • Infectious Disease
  • Sexually Transmitted Disease
  • Investor presentation
  • Company
  • Direct Sales
  • Medical Devices Sales

United Kingdom Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • November 2018
  • 225 pages

United Kingdom Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others Summary GlobalData’s new report, United Kingdom ...

  • United Kingdom
  • Neurology
  • Neurological Disorder
  • Annual report
  • Company
  • Direct Sales
  • Pharmaceutical Revenue

MagForce AG (MF6) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • November 2020
  • 37 pages

Summary MagForce AG (MagForce) is a medical device manufacturing company.The company is engaged in the development of nanotechnology-based therapy for the treatment of cancer. It’s products portfolio ...

  • Europe
  • Germany
  • Cancer
  • Brain Cancer
  • Company research
  • Company
  • Medical Devices Sales

AtriCure Inc (ATRC) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 39 pages

Summary AtriCure Inc (AtriCure) is a provider of medical devices for the treatment of atrial fibrillation (Afib) and related conditions.The company develops, manufacture and sale of cardiac surgical ablation ...

  • United States
  • Europe
  • Cardiovascular Disease
  • Clinical Trial
  • Investor presentation
  • Company
  • Drug Approval
  • Medical Devices Sales

Quarterly Mining Industry Deals Review M&A and Capital Raising - Q1 2020

  • $ 495
  • May 2020
  • 28 pages

Quarterly Mining Industry Deals Review M&A and Capital Raising - Q1 2020 Summary “Quarterly Mining Industry Deals Review M&A and Capital Raising - Q1 2020” report is an essential source of data ...

  • World
  • Colombia
  • Infectious Disease
  • Investor presentation
  • Company
  • Gold Price
  • Copper Sales

FCA: Coronavirus (COVID 19) Company Impact

  • $ 495
  • April 2020
  • 18 pages

FCA: Coronavirus (COVID 19) Company Impact Summary This report aims to help you understand the impact of the COVID-19 outbreak on an automotive OEM Scope - This report has been extracted from GlobaData’s ...

  • China
  • Europe
  • Infectious Disease
  • Investor presentation
  • Company
  • Car Production
  • Car Sales

Shire Company Analysis, Pharma Intelligence

  • $ 3000
  • August 2018
  • 64 pages

PharmaVitae explores Shire’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product ...

  • Europe
  • United States
  • Prescription Drug
  • Blood Disease
  • Company research
  • Company

EU5 Trauma Fixation Market Outlook to 2025

  • $ 5995
  • August 2018
  • 174 pages

EU5 Trauma Fixation Market Outlook to 2025 Summary GlobalData’s new report, EU5 Trauma Fixation Market Outlook to 2025, provides key market data on the EU5 Trauma Fixation market. The report provides ...

  • France
  • Germany
  • Orthopedics
  • Clinical Trial
  • Annual report
  • Company
  • Direct Sales
  • Manufacturing Orders

Insurance Company Profile: Singapore Life

  • $ 995
  • January 2019
  • 24 pages

Insurance Company Profile: Singapore Life Summary Singapore Life is a 100% digital direct insurer offering life cover.It also offers financial solutions to customers to help meet their protection, savings, ...

  • Singapore
  • Bavaria
  • Insurance
  • Pathology
  • Investor presentation
  • Company
  • Life Insurance Claims
  • High Net Worth Individuals Number

Exosomics Siena SpA - Product Pipeline Analysis, 2018 Update

  • $ 750
  • December 2018
  • 36 pages

Summary Exosomics Siena SpA (Exosomics Siena) is a biotechnology company that offers research and development services.The company provides services such as contract research, collaborative project management, ...

  • Sweden
  • Cancer
  • Genetic Testing
  • Investor presentation
  • Company
  • Medical Devices Sales
  • Colorectal Cancer Screening Coverage

EU5 Hearing Aid Devices Market Outlook to 2025

  • $ 5995
  • April 2018
  • 154 pages

EU5 Hearing Aid Devices Market Outlook to 2025 Summary GlobalData’s new report, "EU5 Hearing Aid Devices Market Outlook to 2025", provides key market data on the EU5 Hearing Aid Devices market.The report ...

  • Germany
  • France
  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Annual report
  • Company
  • Medical Technology Density
  • Electricity Price

EU5 Hearing Implants Market Outlook to 2025

  • $ 5995
  • April 2018
  • 74 pages

EU5 Hearing Implants Market Outlook to 2025 Summary GlobalData’s new report, "EU5 Hearing Implants Market Outlook to 2025", provides key market data on the EU5 Hearing Implants market. The report provides ...

  • United Kingdom
  • France
  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Investor presentation
  • Company
  • Plastic Production
  • Direct Sales
About 6100 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Affimed Analyst report

  • January 2022
  • 4 pages
  • Germany
  • United States
  • Cancer
  • Biopharmaceutical
  • Broker research
  • Company

NBT Analyst report January 2022


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on